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Abstract
Background: The objective of the present study was to isolate and purify the protein fraction(s) of llama seminal
plasma responsible for the ovulation-inducing effect of the ejaculate.
Methods: Semen collected from male llamas by artificial vagina was centrifuged and the seminal plasma was
harvested and stored frozen. Seminal plasma was thawed and loaded onto a Type 1 macro-prep ceramic
hydroxylapatite column and elution was carried out using a lineal gradient with 350 mM sodium phosphate. Three
protein fractions were identified clearly (Fractions A, B, and C), where a prominent protein band with a mass of
14 kDa was identified in Fraction C. Fraction C was loaded into a sephacryl gel filtration column for further
purification using fast protein liquid chromatography (FPLC). Isocratic elution resulted in 2 distinct protein fractions
(Fractions C1 and C2). An in vivo bioassay (n = 10 to 11 llamas per group) was used to determine the ovarian
effect of each fraction involving treatment with saline (negative control), whole seminal plasma (positive control),
or seminal plasma Fractions A, B or C2. Ultrasonography was done to detect ovulation and CL formation, and
blood samples were taken to measure plasma progesterone and LH concentrations.
Results: Ovulation and CL formation was detected in 0/10, 10/11, 0/10, 2/11, and 10/11 llamas treated with saline,
whole seminal plasma, Fractions A, B and C2 respectively (P < 0.001). A surge in circulating concentrations of LH
was detected within 2 hours only in llamas treated with either whole seminal plasma or Fraction C2. Plasma
progesterone concentration and CL diameter profiles were greatest (P < 0.05) in llamas treated with Fraction C2.
Conclusion: Ovulation-inducing factor was isolated from llama seminal plasma as a 14 kDa protein molecule that
elicits a preovulatory LH surge followed by ovulation and CL formation in llamas, suggesting an endocrine effect at
the level of the hypothalamus (release of GnRH) or the pituitary (gonadotrophs).
Background
Historically, the role of seminal plasma has been attribu-
ted primarily to its direct effects on spermatozoa; i.e.,
buffering, nutrition, capacitation, and transport [1].
However, recent findings about the systemic effects of
seminal plasma in the female suggest an additional role -
as an inducer of ovulation. The first direct evidence of an
ovulation-inducing factor (OIF) in semen came from
workers in China who reported that ovulation occurred
after intravaginal or intramuscular administration of
Bactrian seminal plasma to female Bactrian camels [2-4].
The existence of the putative OIF garnered little scientific
attention for 20 years, until it was confirmed in a series of
studies involving llamas and alpacas, New World relatives
of camels [5]. Results from this and subsequent studies
document that OIF 1) exists in semen of alpacas, llamas
and koalas (induced ovulators), 2) is a potent stimulator
of LH secretion, 3) has a dose-dependent effect on ovula-
tion rate and CL form and function, and 4) acts via a
systemic rather than a local pathway, at physiologically
relevant doses [5-9].
The discovery of OIF in seminal plasma was made in
species categorized as induced ovulators since factors
influencing the occurrence of ovulation can be studied
without the confounding effects of spontaneous ovula-
tion. Results of recent studies, however, support the
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hypothesis that OIF in seminal plasma is conserved
among species, including those considered to be sponta-
neous ovulators (e.g., bovine, equine and porcine;
[8,10]). Furthermore, OIF in seminal plasma influenced
ovarian function in species considered to be sponta-
neous ovulators; i.e., it induced ovulation in a pre-
pubertal mouse model [11] and altered ovarian follicular
wave dynamics in cows through a suppressive effect on
the dominant follicle [12].
Attempts have been made to isolate and purify OIF in
camel seminal plasma using a combination of anion
exchange and hydrophobic chromatography [13,14]; how-
ever, interpretation of the results is limited because of the
lack of a validated bioassay to quantitatively test the effects
of various fractions. The initial supposition that OIF is
related to the GnRH peptide is reasonable based on LH-
releasing effects on pituitary cells and the presence of
GnRH immuno-reactivity in human seminal plasma
[15,16]. However, the addition of GnRH antibodies to in
vitro rat pituitary cell culture did not block the LH-releasing
effect of alpaca seminal plasma [17], suggesting that OIF
has a different chemical structure than the classic peptide.
The biochemical identity of OIF in seminal plasma
remains unknown. Using a systematic approach to
ablate the bioactivity of llama seminal plasma, results of
a recent study document that OIF is a protein molecule
that is resistant to heat and enzymatic digestion with
proteinase K, and has a molecular mass of more than
about 30 kDa [18]. The objective of the present study
was to isolate and purify the protein fraction(s) of llama
seminal plasma responsible for the ovulation-inducing
effect of the ejaculate.
Methods
Semen collection and preparation
Semen was collected from 3 male llamas (n = 24 ejaculates
per male) over a period of 3 months at the University of
Saskatchewan. Ejaculates were collected by artificial
vagina, and the seminal plasma (total volume approxi-
mately 144 ml) was harvested after centrifugation, diluted,
and stored frozen, as described previously [5]. Upon thaw-
ing, the seminal plasma was pooled and sonicated to
reduce viscosity. Sonification was done on ice using a
Sonifier Cell Disruptor with a microtip (Model W185,
Heat Systems-Ultrasonics, Inc., Plainview, NY, USA) and
applying five 15-second episodes at 70% of maximum
power (35 watts) with 45-second rest periods between
episodes. After sonification, the seminal plasma was
centrifuged at 10,000 × g for 20 minutes to remove parti-
culate matter.
Hydroxylapatite column chromatography
Seminal plasma was loaded onto a Type 1 macro-prep
ceramic hydroxylapatite column (20 μm, BIO-RAD
laboratories, Hercules, CA, USA) that was previously
equilibrated with 10 mM sodium phosphate at a pH of
6.8. Approximately 24-30 mg of seminal plasma total
protein was loaded onto the column (1 cm × 10 cm) for
each of 10 elution replicates (total of 240-300 mg total
protein). The seminal plasma was allowed to bind to the
hydroxylapatite slurry for 30 minutes. Elution was car-
ried out at room temperature using a lineal gradient
with 350 mM sodium phosphate, pH 6.8, and a flow
rate of 0.5 ml/min. Two ml fractions were collected and
their absorbance at 280 nm was measured. Fractions
corresponding to each absorbance peak were pooled,
concentrated and buffer-exchanged with phosphate buf-
fered saline (PBS, pH 7.4) using a 20 ml ultra-filter
device (Vivaspin, Sartorius, Goettingen, Germany) with
a membrane cut-off of 5,000 Da. To examine protein
band profiles, a sample of each fraction was reduced,
denatured, and separated by electrophoresis on 12%
polyacrylamide gel (SDS-PAGE) based on the protocol
of Laemmli 1970. Gels were stained with Coomassie
Blue R-250 (Sigma-Aldrich, St Louis, Missouri, USA) as
described previously [19].
Purification by fast protein liquid chromatography (FPLC)
Approximately 6-8 mg of a broad elution fraction from
the hydroxylapatite column (Fraction C), corresponding
to a prominent protein band at about 14 kDa, was
loaded onto a gel filtration column (SEC, Hi Prep™
26/60 Sepahacryl™ S-100, Amersham Laboratories,
Piscataway, NJ, USA) in each of 10 elution replicates
(60-80 mg total protein in Fraction C). The purification
procedure was carried out at room temperature at a
flow rate of 0.5 ml per minute using fast protein liquid
chromatography (FPLC, Amersham Laboratories). Elu-
tion was performed isocratically using PBS at pH 7.4,
and the absorbance of 4 ml fractions was measured at
280 nm. Fractions corresponding to each protein peak
were pooled and concentrated in PBS at pH 7.4 using
20 ml ultra-filters with a membrane cut-off of 5,000 Da.
Fractions were examined using SDS-PAGE, as described
above.
Bio-effects of purified protein fractions on ovarian
function in llamas
The study was conducted from May to June using a
herd of 55 non-lactating female llamas, ≥4 years of age
and weighing 90-150 kg, at the University of Saskatche-
wan. A preliminary trial (n = 4 llamas per group) was
done initially to test all fractions at the chosen dose.
Llamas were given 5 mg Armour Standard LH (Lutro-
pin-V, Bioniche Animal Health, Belleville, ON, Canada)
i.m. to synchronize follicular wave emergence among
animals [20]. Twelve days after LH treatment, llamas
with a growing follicle ≥8 mm in diameter, determined
Ratto et al. Reproductive Biology and Endocrinology 2011, 9:24
http://www.rbej.com/content/9/1/24
Page 2 of 8
by daily transrectal ultrasonography (7.5 MHz linear-
array transducer, Aloka SSD 900, Tokyo, Japan), were
assigned randomly to treatment groups and given 1.0 ml
i.m. of a) PBS (negative control), b) whole seminal
plasma (SP, positive control, 2.5 mg of total protein),
c) Fraction A (1 mg), d) Fraction B (1 mg), e) Fraction
C1 (1 mg), or f) Fraction C2 (1 mg). The ovaries were
examined daily by transrectal ultrasonography from the
day before treatment (Day -1) to Day 3 to detect ovula-
tion, and every-other-day to Day 15 to monitor CL
development, as described [5]. Ovulation was defined as
the sudden disappearance of a large follicle (≥8 mm)
that was detected during the previous examination, and
was confirmed by later detection of a CL. The ensuing
full experiment (n = 10 or 11 llamas per group) was
similar to the preliminary trial except that Fraction C1
was omitted because it did not elicit ovulations in the
preliminary trial and was not a prominent feature in the
FPLC chromatogram or SDS-PAGE. Llamas used in the
preliminary trial were also used in the full experiment
by randomly assigning to a treatment group other than
that assigned in the preliminary trial.
Blood samples for progesterone measurement were col-
lected into heparinized tubes by jugular venipuncture on
Day -1, 0, 1, and every-other-day to Day 15. Blood samples
were centrifuged at 1700 × g for 25 minutes and the
plasma was stored at -20°C. Plasma progesterone concen-
trations were determined using a commercial, double-
antibody radioimmunoassay kit (Coat-a-Count total pro-
gesterone, Diagnostic Products Corporation, Los Angeles,
CA, USA), as described previously [5,21]. All samples were
analyzed in duplicate in a single assay. The intra-assay
coefficients of variation were 4.5%, 5.1% and 3.6% for
reference plasma progesterone concentrations of 1.7, 3.0,
and 15.9 ng/ml, respectively.
Blood samples for LH measurement were collected
from a subset of 5 randomly chosen llamas in each
group. Blood was collected in heparinized tubes (5 ml)
every 15 minutes for 8 hours starting immediately
before treatment (Time 0 = treatment). A jugular
catheter (inner and outer diameters of 1.0 and 1.5 mm,
respectively) was fixed in place one day before treat-
ment to minimize the effects of handling stress on
plasma LH concentrations [5]. Blood samples were
centrifuged at 1700 × g for 25 minutes and the plasma
was stored at -20°C. Plasma LH concentrations were
measured using a monoclonal LH antibody (518B7 lot
#12) in a double-antibody radioimmunoassay [5,22].
Concentrations of LH are expressed in terms of
NIAMDD-oLH-24. The minimum detectable limit of
the assay was 0.13 ng/ml. The range of the standard
curve was 0.06 ng/ml (93.8% ligand labeled LH) to
8 ng/ml (7.0% ligand labeled LH). The intra- and
inter-assay coefficients of variation were 5.2% and
5.3%, respectively, for the high reference plasma LH
concentration (1.15 ng/ml), and 9.7% and 10.2%,
respectively, for the low reference plasma LH concen-
tration (0.52 ng/ml).
Statistical analyses
Data from the preliminary trial were analyzed separately
from the main experiment and involved comparison of
ovulation rate only. Single-point measurements (i.e., fol-
licle diameter at the time of treatment, maximum CL
diameter, day on which the CL was first detected, onset
of CL regression) were compared between groups by
analyses of variance. For serial observations (CL dia-
meter, plasma LH and progesterone concentrations),
data were centralized to the day of treatment (Day 0)
and compared by analysis of variance for repeated mea-
sures using the Mixed Procedures of SAS (Statistical
Analysis System Institute Inc., Cary, NC, USA) to deter-
mine the effects of treatment, time, and treatment-by-
time interaction. When main effects or their interaction
were significant (P ≤ 0.05), means at a given time were
compared among groups by the method of least signifi-
cant difference. Ovulation rates were compared among
groups by Fishers exact test.
The experimental protocol was approved by the
University Committee on Animal Care and Supply in
accordance with the guidelines of the Canadian Council
on Animal Care.
Results
Hydroxylapatite column and fast protein liquid
chromatography
Three protein fractions of llama seminal plasma (A, B
and C) were eluted from a hydroxylapatite gravity chro-
matography column (Figure 1). Fraction C was com-
prised of a major 14 kDa protein, observed on
denatured SDS-PAGE (Figure 1). Fraction C was subse-
quently loaded into a gel filtration column and sepa-
rated into purified protein fractions using FPLC. Two
sharp peaks (C1 and C2) were detected after gel filtration
chromatography (Figure 2). The 14 kDa protein pre-
viously detected by hydroxylapatite column chromato-
graphy (Figure 1) was the major constituent of purified
Fraction C2 identified by FPLC (Figure 2).
Bioassay of purified protein fractions
In the preliminary trial, ovulations were detected only in
groups treated with whole seminal plasma (positive con-
trol, 4/4) or Fraction C2 (4/4; Table 1). Based on this
result, an expanded trial was done using a larger num-
ber of animals (Table 2). Ovulations were detected in
>90% of llamas treated with either whole seminal plasma
(positive control) or Fraction C2, and in few (Fraction B)
or none (Fraction A and PBS) of the llamas in the other
Ratto et al. Reproductive Biology and Endocrinology 2011, 9:24
http://www.rbej.com/content/9/1/24
Page 3 of 8
Figure 1 Protein fractions of llama seminal plasma. Fractions A, B and C were eluted on hydroxylapatite gravity chromatography columns
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Figure 2 Separation of protein Fraction C of llama seminal plasma. Separation was done using sephacryl gel filtration fast protein liquid
chromatography (FPLC) and isocratic elution with phosphate buffered saline (left). Fraction C was isolated previously by hydroxylapatite gravity
column chromatography. Vertical lines along the x-axis represent fractions collected and examined. The protein band at about 14 kDa on
denaturing 12% SDS-PAGE (right) was the major constituent of Fraction C2 (right).
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groups (Table 2). Subsequent to ovulation, the CL was
detected earlier (P < 0.01) and attained a greater dia-
meter (P < 0.01) in llamas treated with Fraction C2 than
in those treated with whole seminal plasma (Table 3).
The day-to-day CL diameter profile was greater in lla-
mas treated with Fraction C2 than in those treated with
whole seminal plasma (Figure 3). Similarly, plasma pro-
gesterone concentrations were highest in llamas treated
with Fraction C2 (Figure 3). Mean plasma progesterone
concentration increased marginally in the Fraction B
group as a result of only 2 ovulations. Progesterone con-
centrations remained basal in llamas treated with Frac-
tion A or PBS.
Plasma LH concentration surged during the 8-hour
period after treatment (P < 0.01) in llamas treated with
whole seminal plasma and those treated with Fraction
C2, but remained unchanged in llamas treated with PBS
or Fractions A or B (Figure 4). Plasma LH profiles were
similar in llamas treated with whole plasma and those
treated with Fraction C2; LH began to increase (P <
0.01) by 1.5 hours after treatment, peaked at 3 hours,
and declined to pre-treatment levels by 7 hours after
treatment.
Discussion
A highly purified protein isolated from llama seminal
plasma was identified as OIF using a combination of
hydroxylapatite and gel-filtration chromatography.
The purified protein elicited a preovulatory LH surge
followed by ovulation and corpus luteum formation in
llamas after intramuscular administration. The chroma-
tographic strategy used in this study revealed a single
bioactive fraction in llama seminal plasma with a molecu-
lar mass of approximately 14 kDa. In contrast, two bioac-
tive fractions of Bactrian seminal plasma were detected
in a study involving anion exchange chromatography, but
molecular masses were not reported [14]. In this regard,
the molecular mass of the protein isolated in the present
study (based on the band pattern on denatured SDS
PAGE) represents about half that found in a previous
study [18] in which only the seminal plasma fraction
greater than the nominal molecular mass cut-off 30 kDa
(using centrifugal filtration devices) elicited ovulation in
llamas. In the same study, however, partial enzymatic
digestion with proteinase K did not ablate bioactivity
despite rendering all proteins to ≤19 kDa [18]. Whether
the 14 kDa protein identified in the present study is part
of a larger protein complex or represents a bioactive pro-
hormone form remains to be determined.
Results of the present and previous studies on seminal
plasma are consistent with the hypothesis that OIF acts
systemically to induce ovulation via a surge-release of
LH, but results are not consistent with the hypothesis
that OIF is related to GnRH. The molecular mass of the
protein isolated in this study, and the effects of enzymatic
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Female llamas (n = 4 per group) were given whole seminal plasma (SP, positive control), Fractions A or B (isolated by hydroxylapatite column chromatography),
Fractions C1 or C2 (isolated by gel filtration chromatography), or phosphate buffered saline (PBS, negative control).
* No significant differences among groups.
a,b Proportions with different superscripts are different (P < 0.03).
Table 2 Ovulation-inducing effect of protein fractions of




























Female llamas (n = 10-11 per group) were given whole seminal plasma (SP,
positive control), Fractions A or B (isolated by hydroxylapatite column
chromatography), Fraction C2 (isolated by gel filtration chromatography), or
phosphate buffered saline (PBS, negative control).
* No significant difference among groups.
a,b Proportions with different superscripts are different (P < 0.001).
Table 3 Effect of protein fractions of llama seminal









(Day 0 = treatment)
2.9 ± 0.1a 2.5 ± 05ab 2.1 ± 0.2b
Maximum CL
diameter (mm)
11.0 ± 0.4a 12.0 ± 1.0ab 13.3 ± 0.4b
CL diameter at
Day 8 (mm)
10.4 ± 0.4a 11.3 ± 0.3ab 12.4 ± 0.4b
CL diameter on
Day 15 (mm)
4.9 ± 0.2a 4.5 ± 0.5a 6.4 ± 0.5b
Female llamas were given whole seminal plasma (SP, positive control),
Fraction B (isolated by hydroxylapatite column chromatography) or Fraction
C2 (isolated by gel filtration chromatography).
a,b Values with no common superscripts are different (P < 0.01).
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digestion found in a previous study [18] document that
OIF is a larger protein than GnRH, and the addition of
anti-GnRH antibodies to in vitro culture of pituitary cells
did not abolish the effect of seminal plasma on LH secre-
tion [17]. The post-treatment surge in circulating con-
centrations of LH observed in the present study is
consistent with that of previous studies in which intra-
muscular administration of llama or alpaca seminal
plasma elicited an LH surge that began within 1 hour of
treatment, peaked at 3 hours, and returned to baseline by
7 to 8 hours [5,9]. Whether OIF in seminal plasma med-
iates LH release solely at the level of the pituitary or by
stimulating GnRH neurons in the hypothalamus remains
unknown. However, LH release was more sustained in
llamas given OIF than in those given GnRH [5], and the
luteotrophic effects of OIF observed in the present study
are consistent with the dose-dependent effects of seminal
plasma reported in previous studies [5,9]. The more
luteotrophic effect observed in llamas given purified OIF
(Fraction C2) than in those given whole seminal plasma
was unexpected and requires confirmation. It may be
attributed to differences in absolute dose of OIF between
the two treatments, though no differences in LH
response were detected. Whether the difference in LH
Figure 3 Effect of protein fractions of llama seminal plasma on CL diameter and plasma progesterone concentrations in llamas.
Female llamas were given whole seminal plasma (SP, positive control), Fractions A or B (isolated by hydroxylapatite column chromatography),
Fraction C2 (isolated by gel filtration chromatography), or phosphate buffered saline (PBS, negative control).
abcd Within days, values with no
common superscript are different (P < 0.05).
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release between groups was too small to detect with our
assay or the effect of OIF is also exerted at the local level
(i.e., granulosa cells) remains to be elucidated.
An ovulation-inducing role of prostaglandins and
estrogens in seminal plasma has been postulated in pigs
[23,24], but results of the present and previous studies
provide compelling documentation that OIF is neither a
prostaglandin nor an estrogen [18]. The bioactivity of
llama seminal plasma was not abolished by steroid
extraction, and administration of fractions containing
molecules <5 kDa did not induce ovulation [18]; prosta-
glandin and estrogen have molecular masses of 273 Da
and 354 Da, respectively. Furthermore, elevations in cir-
culating concentrations of estradiol during ovarian folli-
cular wave development were not associated with LH
release or ovulation in llamas and alpacas [25,26].
Results provide strong support for the hypothesis that
ovulation in camelid species is elicited by an endocrine
effect of OIF protein in seminal plasma. Camelids are
classified as induced ovulators [27,28], but the results of
early classic studies did not clearly distinguish between
the effects of physical stimulation of copulation and
exposure to constituents of the ejaculate. An important
advantage over early studies is the availability of trans-
rectal ultrasonography as a method to detect ovulation
and CL development in more recent studies. Ultrasono-
graphic detection of ovarian response in llamas and
alpacas provides a rapid and robust in vivo bioassay for
testing the effects of physical stimuli and different frac-
tions of seminal plasma [5,7,18]. Collectively from 2 pre-
vious ultrasound studies [5,7], 42/45 (93%) llamas and
alpacas ovulated after intramuscular administration of
seminal plasma and 0/42 (0%) ovulated after transcervi-
cal intrauterine deposition of saline, with or without
endometrial currettage. Similarly, the ovulation rate of
llamas treated intramuscularly with whole seminal
plasma or Fraction C2 in the present study was 93%.
Using the same llama ovulation bioassay, OIF has also
been detected in the seminal plasma of other species
(bull, stallion, boar, rabbit), suggesting that it is widely
conserved [8,10,29].
Identification of the amino acid sequence and struc-
tural form of the OIF protein will be important in devel-
oping tools to examine the mechanism of action of OIF,
including the tissue source within the male and the tis-
sue targets within the female. Development of tools to
measure OIF and OIF receptors will also permit test of
the hypothesis that some as yet unexplained causes of
infertility are based on alterations in the sensitivity to,
or abundance of, this molecule. Recent documentation
of the presence of OIF in the seminal plasma of several
mammalian species suggests an evolutionary link
between species classified as induced or spontaneous
ovulators. Further characterization of OIF is needed to
determine the relative prevalence and functional role of
OIF among species.
Figure 4 Effect of protein fractions of llama seminal plasma on circulating LH concentration in llamas. Female llamas were given whole
seminal plasma (SP, positive control), Fractions A or B (isolated by hydroxylapatite column chromatography), Fraction C2 (isolated by gel filtration
chromatography), or phosphate buffered saline (PBS, negative control). *Interval during which values in SP and C2 were higher (P < 0.05) than in
other groups.
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In conclusion, OIF was isolated from llama seminal
plasma as a 14 kDa protein molecule using a two step
combination of hydroxylapatite and gel filtration chro-
matography. Systemic administration of purified OIF
resulted in a preovulatory LH surge followed by ovula-
tion and CL formation in llamas suggesting an endo-
crine effect at the level of the hypothalamus (release of
GnRH) or the pituitary (gonadotrophs).
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